PORTAL: Patient-reported Outcomes After Routine Treatment of Atypical Lesions
Running, not enrolling · Not applicable
Conditions studied: Breast Cancer
In brief
This research study is evaluating how patients feel physically and emotionally after a prior breast biopsy for specific breast conditions (including atypical lesions such as atypical ductal hyperplasia (ADH), atypical lobular hyperplasia (ALH), lobular carcinoma in situ (LCIS), and/or ductal carcinoma in situ (DCIS))
Key facts
- Study ID
- NCT03070236
- Run by
- Dana-Farber Cancer Institute
- People needed
- 912
- Starts
- 2017-12-01
- Expected to finish
- 2030-02-25
- Last updated by the study team
- 2026-02-03
Who can join
Age: 18 and older. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- Patients treated at DUMC, DFCI, MDACC, MGH, NWH, or DFCI @ SSH with a diagnosis of DCIS, LCIS, ADH, or ALH who are also:
- Age 18 or more at index diagnosis
- Diagnosed with DCIS, LCIS, ADH, or ALH between January 1, 2012 and June 30, 2017
- Able to read either English or Spanish and able to provide written (via paper), or on-line informed consent
- Treated and followed at one of the study sites (including affiliated network sites) and for whom treatment and surveillance data are available, for at least 1 year of follow up after date of diagnosis
- Participants with bilateral synchronous or metachronous disease (DCIS, LCIS, ADH, ALH) are eligible
You may not qualify if…
- Ever had a diagnosis of invasive or microinvasive breast cancer
- DCIS prior to index lesion or history of progressive/recurrent DCIS after treatment
- Other cancers (excluding non-melanoma skin cancer) diagnosed within 5 years prior to index lesion, including concurrent invasive cancer diagnosis and up to the present time of participant's approach to invitation into the study
- Patients identified by treating physician as being unsuitable for contact
Where it is running
- Massachusetts General Hospital — Boston, Massachusetts, United States
- Dana-Farber Cancer Institute — Boston, Massachusetts, United States
- Newton-Wellesley Hospital — Newton, Massachusetts, United States
- Dana-Farber/Brigham and Women's Cancer Center in clinical affiliation with South Shore Hospital — Weymouth, Massachusetts, United States
- Duke University Medical Center — Durham, North Carolina, United States
- MD Anderson Cancer Center — Houston, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.